Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases - An update

Journal of NeuroVirology

Volumn 8, Issue SUPPL. 2, 2002, Pages 122-128

  Cinque, Paola ^a   Bossolasco, Simona ^a   Bestetti, Arabella ^a   Sala, Serena ^a   Pierotti, Chiara ^a   Lazzarin, Adriano ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cerebrospinal fluid; HIV; Nucleic acid amplification; Opportunistic infections; Polymerase chain reaction; Progressive multifocal leukoencephalopathy

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR;

ANTIBIOTIC RESISTANCE; BRAIN LYMPHOMA; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FOLLOW UP; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; INTERMETHOD COMPARISON; MOLECULAR BIOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; OPPORTUNISTIC INFECTION; PATHOGENESIS; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036948152     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280290167957     Document Type: Review

References (23)

1. Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL (1997). JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 176: 1-8.
2. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA (1995). Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 172: 527-531.
3. Bastien P (2002). Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 96(suppl 1): S205-S215.
4. Bestetti A, Pierotti C, Terreni M, Zappa A, Vago L, Lazzarin A, Cinque P (2001). Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol 39: 1148-1151.
5. Bossolasco S, Bestetti A, Sala S, Brambilla AM, Viganò MG, Giudici B, Cinque P (2002a). Diagnosis and monitoring of HIV-related PML by quantitative real-time PCR for JCV DNA. Presented at the Conjoint 4th International Symposium on NeuroVirology and 10th Conference on Neuroscience of HIV infection. June 19-22, 2002, Dusseldorf, Germany.
6. Bossolasco S, Bestetti A, Sala S, Lazzarin A, Linde A, Cinque P (2002b). Real-time polymerase chain reaction for diagnosis and treatment follow-up of herpesvirus central nervous system infections in HIV-infected patients. Presented at the Conjoint 4th International Symposium on NeuroVirology and 10th Conference on Neuroscience of HIV infection. June 19-22, 2002, Düsseldorf, Germany.
7. Bossolasco S, Cinque P, Ponzoni M, Viganò MG, Lazzarin A, Linde A, Falk K (2002c). Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J NeuroVirol 5: 432-438.
8. Bustin SA (2000). Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193.
9. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon AM, Klapper PE (1998). Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. J NeuroVirol 4: 120-132.
10. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11: 1-17.
11. Eggers C, Stellbrink HJ, Buhk T, Dorries K (1999). Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy-a longitudinal study. J Infect Dis 180: 1690-1694.
12. Garcia De Viedma D, Diaz Infantes M, Miralles P, Berenguer J, Marin M, Munoz L, Bouza E (2002). JC virus load in multifocal progressive leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival and the volume of neurological lesions. Clin Infect Dis 34: 1568-1575.
13. Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95-99.
14. Jensen PN, Major EO (2001). A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region J NeuroVirol 74: 280-287.
15. MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF (1991). Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: 969-973.
16. Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467-2472.
17. Pfister L-A, Letvin N, Koralnik I (2001). JC virus regulatory region tandem repeats in plasma and central nervous system correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 75: 5672-5676.
18. Preiser W, Elzinger B, Brink NS (2000). Quantitative molecular virology in patient management. J Clin Pathol 53: 76-83.
19. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, and the Multicenter AIDS Cohort Study (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.
20. Sala M, Vartanian J-P, Kousignian P, Delfraissy J-F, Taoufik Y, Wain-Hobson S, Gasnault J (2001). Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. J Gen Virol 82: 899-907.
21. Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 178: 1816-1820.
22. Wolf DG, Lee DJ, Spector SA (1995). Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 39: 2552-2554.
23. Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45: 816-821.